Experimental NIH malaria monoclonal antibody protective in Malian children
Mid-stage trial shows treatment prevents infection, disease
2024-04-26
(Press-News.org) One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country’s six-month malaria season, according to the results of a mid-stage clinical trial. The trial assessed an investigational monoclonal antibody developed by scientists at the National Institutes of Health (NIH), and results appear in The New England Journal of Medicine.
“A long-acting monoclonal antibody delivered at a single health care visit that rapidly provides high-level protection against malaria in these vulnerable populations would fulfill an unmet public health need,” said Dr. Jeanne Marrazzo, director of the National Institute of Allergy and Infectious Diseases, part of NIH.
The clinical trial assessed two dose levels, with 19% of the 300mg-dose group and 28% of the 150mg-dose group developing symptomatic malaria, providing protective efficacy of 77% and 67% against symptomatic malaria, respectively. Among children who received placebo, 81% became infected with Plasmodium falciparum, and 59% had symptomatic malaria during the six-month study period. The authors note that the trial demonstrated for the first time that a single dose of a monoclonal antibody given by subcutaneous injection can provide high-level protection against malaria in children in an area of intense malaria transmission.
In 2022, the P. falciparum parasite caused a majority of the nearly 250 million estimated cases of malaria globally and most of the more than 600,000 malaria deaths, according to the World Health Organization. Most malaria cases and deaths are among children in Africa. Malaria parasites such as P. falciparum are transmitted to people by mosquito bites.
In 2020, scientists at NIAID’s Vaccine Research Center reported that they had isolated the antibody from a volunteer who had been vaccinated with an experimental malaria vaccine. The antibody was modified with a mutation that prolonged its durability in the bloodstream following administration. In an earlier study, conducted in Mali by the same research group, a previously discovered antibody was highly protective against P. falciparum infection in adults when given intravenously. However, the new antibody was shown to be more potent in animal studies and was manufactured at a higher concentration than CIS43LS, allowing it to be given by subcutaneous injection.
The trial in Mali took place in two parts, first to assess safety in a small number of adults and children, and then in a larger clinical efficacy trial involving 225 children. The efficacy trial took place from July 2022 to January 2023 and included healthy children 6 to 10 years of age, 75 of whom received a 300 mg dose, 75 a 150 mg dose, and 75 of whom received a placebo.
The researchers are continuing clinical development of the experimental antibody, focusing on other high-risk populations, such as infants and young children, children hospitalized with severe anemia, and pregnant women. An ongoing clinical trial in Kenya is assessing the efficacy of the antibody in children 5 months to 5 years of age over a 12-month study period, and scientists are also conducting a clinical trial in Mali to assess the antibody in women of childbearing potential to prepare to test the antibody in pregnancy.
NIAID led the clinical trial in conjunction with the University of Sciences, Techniques and Technologies of Bamako, Mali, through NIAID’s Division of Intramural Research International Centers of Excellence in Research (ICER) program. For more details about the clinical trial, see ClinicalTrials.gov using identifier NCT05304611.
Reference:
K Kayentao et al. Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria. The New England Journal of Medicine DOI: 10.1056/NEJMoa2312775 (2024).
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit https://www.nih.gov/.
NIH...Turning Discovery Into Health®
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2024-04-26
Scientists have shed light on a new, transformative approach that could help resolve a dispute over the Nile river’s water resources.
The Nile is one of the longest rivers globally and spreads over 11 countries in East Africa, supplying water, energy production, environmental quality and cultural wealth. However, the use of Nile resources has been a long-standing source of tension, often overshadowing opportunities for cooperation and mutual benefit.
But as the demand for energy, water, and food in Africa is steadily increasing, the study, led by The University of Manchester in collaboration with regional organisations, offers a glimmer of hope at a resolution.
The research, ...
2024-04-26
Housing insecurity is an issue for 1 in 20 patients who go to emergency departments at major medical centers in the Southeast, according to a Vanderbilt University Medical Center (VUMC) study published in JAMA Network Open.
These patients were more likely to present with a chief complaint of suicide, to be uninsured, and to have multiple visits during the study period from Jan. 5 to May 16, 2023.
“This points to the importance of prioritizing mental health care and homeless ...
2024-04-26
For undocumented Latinx patients who sought care in the emergency room during the pandemic, the reported rate of having received the COVID-19 vaccine was found to be the same as U.S. citizens, a new UCLA Health study found. These findings surprised researchers, given that COVID-19 disproportionately affected the Latinx community in infections, hospitalizations, and death.
Dr. Jesus R. Torres, lead study author and emergency medicine physician at UCLA Health, aimed to study undocumented people because they tend not to be identified in existing research even though they comprise approximately 3% of the ...
2024-04-26
If instructed to “Place a cooled apple into the microwave,” how would a robot respond?
Initially, the robot would need to locate an apple, pick it up, find the refrigerator, open its door, and place the apple inside. Subsequently, it would close the refrigerator door, reopen it to retrieve the cooled apple, pick up the apple again, and close the door. Following this, the robot would need to locate the microwave, open its door, place the apple inside, and then close the microwave door. Evaluating how well these steps are executed exemplifies the essence of ...
2024-04-26
Traditional memory devices are volatile and the current non-volatile ones rely on either ferromagnetic or ferroelectric materials for data storage. In ferromagnetic devices, data is written or stored by aligning magnetic moments, while in ferroelectric devices, data storage relies on the alignment of electric dipoles. However, generating and manipulating magnetic fields is energy-intensive, and in ferroelectric memory devices, reading data destroys the polarized state, requiring the memory cell to be re-writing.
Multiferroic materials, which contain both ferroelectric and ferromagnetic orders, offer a promising solution for more efficient ...
2024-04-26
In a new study published in Engineering, Academician Wu Jiangxing’s research team unveils a theoretical framework that could revolutionize the landscape of network systems and architectures. The paper titled “Theoretical Framework for a Polymorphic Network Environment,” addresses a fundamental challenge in network design—achieving global scalability while accommodating the diverse needs of evolving services.
For decades, the quest for an ideal network capable of seamlessly scaling across various dimensions has remained elusive. The team, however, has identified a critical barrier known as the “impossible service-level ...
2024-04-26
Electric tractors are intended to be used in the field instead of traditional fuel tractors and can be used in greenhouse planting, indoor farming, mountainous operations, and other special operating scenarios. Unlike traditional fuel tractors, electric tractors have no exhaust emissions, rapid drive system response, flexible power output, or other advantages. These scenarios require electric tractors to be able to adapt to complex drive and operating environments, putting higher requirements on the design of electric tractors and their control systems. Therefore, ...
2024-04-26
Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. However, the risk of arrhythmias following this procedure is reportedly high. In a recent study, researchers from Japan tested a novel approach that involves injecting ‘cardiac spheroids,’ cultured from human stem cells, directly into damaged ventricles. The highly positive outcomes observed in primate models highlight the potential of this strategy.
Cardiovascular diseases are still among the top causes of death worldwide, and especially prevalent ...
2024-04-26
Damon Runyon has announced its 2024 Quantitative Biology Fellows, four exceptional early-career scientists who are bringing cutting-edge computational tools to bear on some of the most important questions in cancer biology. From the packaging of DNA to mechanisms of chemotherapy resistance, their projects aim to shed light on these fundamental questions through large-scale data collection, mathematical modeling, and quantitative analysis.
“In the five years since we named the first class of Quantitative Biology Fellows, it has only become more evident that these scientists bring fresh perspectives and creative ...
2024-04-26
Athens, Greece – 26 April 2024: Climbing stairs is associated with a longer life, according to research presented today at ESC Preventive Cardiology 2024, a scientific congress of the European Society of Cardiology (ESC).1
“If you have the choice of taking the stairs or the lift, go for the stairs as it will help your heart,” said study author Dr. Sophie Paddock of the University of East Anglia and Norfolk and Norwich University Hospital Foundation Trust, Norwich, UK. “Even brief bursts of physical activity have beneficial health impacts, and short bouts of stair climbing should be an achievable target to integrate into ...
LAST 30 PRESS RELEASES:
[Press-News.org] Experimental NIH malaria monoclonal antibody protective in Malian children
Mid-stage trial shows treatment prevents infection, disease
